CRISPR THERAPEUTICS AG (CRSP) FY2026 Q2 Balance Sheet

CRISPR THERAPEUTICS AG (CRSP) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

2,650,770,000 US dollars

Current assets

2,371,770,000 US dollars

Non-current assets

279,000,000 US dollars

Liabilities

904,219,000 US dollars

Current liabilities

132,896,000 US dollars

Non-current liabilities

771,323,000 US dollars

Equity

1,746,551,000 US dollars

Marketable securities

2,073,015,000 US dollars

Cash and cash equivalents

291,337,000 US dollars

Prepaid expenses and other current assets

7,418,000 US dollars

Operating lease assets

125,592,000 US dollars

Property and equipment, net

108,068,000 US dollars

Other non-current assets

37,711,000 US dollars

Restricted cash

7,629,000 US dollars

Accrued expenses

70,278,000 US dollars

Operating lease liabilities

18,646,000 US dollars

Other current liabilities

16,982,000 US dollars

Deferred revenue, current

15,189,000 US dollars

Accounts payable

11,307,000 US dollars

Accrued tax liabilities

494,000 US dollars

Long-term debt

586,198,000 US dollars

Operating lease liabilities, net of current portion

178,904,000 US dollars

Other non-current liabilities

6,221,000 US dollars

Additional paid-in capital

3,909,746,000 US dollars

Common shares, CHF 0.03 nominal value, 144,447,967 and 132,477,166 shares authorized at June 30, 2026 and December 31, 2025, respectively, 96,761,275 and 96,009,657 shares issued at June 30, 2026 and December 31, 2025, respectively, 96,660,959 and 95,894,341 shares outstanding at June 30, 2026 and December 31, 2025, respectively

3,130,000 US dollars

Accumulated deficit

negative 2,161,636,000 US dollars

Accumulated other comprehensive (loss) income

negative 4,629,000 US dollars

Treasury shares, at cost, 100,316 and 115,316 shares at June 30, 2026 and December 31, 2025, respectively.

negative 60,000 US dollars

Gross equity (calculated)

3,912,876,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.